(IPS) Ipsos - Overview
Stock: Survey-Based Research, Data Analytics, Audience Measurement, Brand Tracking, AI
Dividends
| Dividend Yield | 4.31% |
| Yield on Cost 5y | 7.34% |
| Yield CAGR 5y | 19.74% |
| Payout Consistency | 98.1% |
| Payout Ratio | 45.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.00 |
| Alpha | -30.20 |
| Character TTM | |
|---|---|
| Beta | 0.114 |
| Beta Downside | 0.186 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.98% |
| CAGR/Max DD | -0.30 |
Description: IPS Ipsos January 15, 2026
Ipsos SA (ticker IPS) is a global market-research firm headquartered in Paris that delivers end-to-end survey-based intelligence across Europe, the Middle East, Africa, the Americas and APAC. Its service stack spans data collection, processing, integration and analysis, plus delivery formats such as dashboards and activation tools. Core offerings include audience measurement, brand health tracking, automotive & mobility insights, corporate reputation, customer experience, healthcare research, and specialized platforms like Ipsos MMA, Ipsos UU, Synthesio and a DIY solution (Ipsos.Digital). The firm also leverages AI, machine-learning, big-data analytics, behavioral science and neuroscience to augment traditional methodologies such as device-agnostic and programmatic sampling.
From a financial-market perspective, Ipsos reported FY 2023 revenue of roughly €2.3 billion, with an operating margin hovering around 10 %-a level that is modestly above the median for the Research & Consulting Services sub-industry. Growth in its AI-driven analytics unit accelerated to double-digit year-over-year, reflecting broader sector demand for real-time, predictive insights as advertisers shift spend toward programmatic channels. Macro-drivers that could materially affect Ipsos include global advertising spend (projected to grow ~5 % CAGR through 2027), tightening data-privacy regulations in the EU (which increase the value of compliant, first-party data), and the rising importance of ESG and sustainability metrics that spur demand for specialized consumer sentiment research.
For a deeper dive into how Ipsos’ valuation compares with peers and the impact of these trends, you might explore the ValueRay platform for independent, data-rich analysis.
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 334.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 7.65 > 1.0 |
| NWC/Revenue: 6.00% < 20% (prev 9.40%; Δ -3.40% < -1%) |
| CFO/TA 0.22 > 3% & CFO 627.4m > Net Income 334.5m |
| Net Debt (377.5m) to EBITDA (765.3m): 0.49 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.5m) vs 12m ago -2.30% < -2% |
| Gross Margin: 42.32% > 18% (prev 0.19%; Δ 4213 % > 0.5%) |
| Asset Turnover: 157.6% > 50% (prev 132.4%; Δ 25.13% > 0%) |
| Interest Coverage Ratio: 15.29 > 6 (EBITDA TTM 765.3m / Interest Expense TTM 36.5m) |
Altman Z'' 2.75
| A: 0.09 (Total Current Assets 946.6m - Total Current Liabilities 687.4m) / Total Assets 2.85b |
| B: 0.02 (Retained Earnings 53.2m / Total Assets 2.85b) |
| C: 0.20 (EBIT TTM 557.6m / Avg Total Assets 2.74b) |
| D: 0.69 (Book Value of Equity 983.3m / Total Liabilities 1.42b) |
| Altman-Z'' Score: 2.75 = A |
Beneish M -3.60
| DSRI: 0.80 (Receivables 568.5m/575.6m, Revenue 4.32b/3.49b) |
| GMI: 0.44 (GM 42.32% / 18.53%) |
| AQI: 1.06 (AQ_t 0.62 / AQ_t-1 0.58) |
| SGI: 1.24 (Revenue 4.32b / 3.49b) |
| TATA: -0.10 (NI 334.5m - CFO 627.4m) / TA 2.85b) |
| Beneish M-Score: -3.60 (Cap -4..+1) = AAA |
What is the price of IPS shares?
Over the past week, the price has changed by -7.87%, over one month by -5.01%, over three months by +3.97% and over the past year by -24.82%.
Is IPS a buy, sell or hold?
What are the forecasts/targets for the IPS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 57.3 | 73.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 32.5 | -1.5% |
IPS Fundamental Data Overview February 03, 2026
P/E Trailing = 8.7628
P/E Forward = 6.2228
P/S = 0.6294
P/B = 1.071
Revenue TTM = 4.32b EUR
EBIT TTM = 557.6m EUR
EBITDA TTM = 765.3m EUR
Long Term Debt = 487.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 50.9m EUR (from shortTermDebt, last quarter)
Debt = 627.9m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 377.5m EUR (from netDebt column, last quarter)
Enterprise Value = 1.92b EUR (1.55b + Debt 627.9m - CCE 250.4m)
Interest Coverage Ratio = 15.29 (Ebit TTM 557.6m / Interest Expense TTM 36.5m)
EV/FCF = 4.14x (Enterprise Value 1.92b / FCF TTM 464.3m)
FCF Yield = 24.13% (FCF TTM 464.3m / Enterprise Value 1.92b)
FCF Margin = 10.75% (FCF TTM 464.3m / Revenue TTM 4.32b)
Net Margin = 7.74% (Net Income TTM 334.5m / Revenue TTM 4.32b)
Gross Margin = 42.32% ((Revenue TTM 4.32b - Cost of Revenue TTM 2.49b) / Revenue TTM)
Gross Margin QoQ = 68.39% (prev 68.93%)
Tobins Q-Ratio = 0.68 (Enterprise Value 1.92b / Total Assets 2.85b)
Interest Expense / Debt = 2.72% (Interest Expense 17.1m / Debt 627.9m)
Taxrate = 26.60% (9.80m / 36.8m)
NOPAT = 409.3m (EBIT 557.6m * (1 - 26.60%))
Current Ratio = 1.38 (Total Current Assets 946.6m / Total Current Liabilities 687.4m)
Debt / Equity = 0.44 (Debt 627.9m / totalStockholderEquity, last quarter 1.43b)
Debt / EBITDA = 0.49 (Net Debt 377.5m / EBITDA 765.3m)
Debt / FCF = 0.81 (Net Debt 377.5m / FCF TTM 464.3m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.20% (Net Income 334.5m / Total Assets 2.85b)
RoE = 22.97% (Net Income TTM 334.5m / Total Stockholder Equity 1.46b)
RoCE = 28.69% (EBIT 557.6m / Capital Employed (Equity 1.46b + L.T.Debt 487.4m))
RoIC = 21.54% (NOPAT 409.3m / Invested Capital 1.90b)
WACC = 5.08% (E(1.55b)/V(2.17b) * Re(6.33%) + D(627.9m)/V(2.17b) * Rd(2.72%) * (1-Tc(0.27)))
Discount Rate = 6.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF Debug] Terminal Value 88.43% ; FCFF base≈369.9m ; Y1≈456.3m ; Y5≈777.1m
Fair Price DCF = 515.7 (EV 22.63b - Net Debt 377.5m = Equity 22.25b / Shares 43.2m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -2.87 | EPS CAGR: -45.24% | SUE: 0.0 | # QB: 0
Revenue Correlation: -16.98 | Revenue CAGR: -23.38% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=5.41 | Chg30d=+0.037 | Revisions Net=+0 | Growth EPS=+7.7% | Growth Revenue=+3.3%